{CurrentPage:PageName}

About Us

Shared Savings Program Public Reporting

ACO Name and Location

Covenant ACO, Inc.

2107 Oxford Ave, Suite 200, Lubbock, TX, 79410, U.S.A.

ACO Primary Contact

Ashlyn Frazier

806-725-0711

Organizational Information

ACO Participants:

ACO Governing Body:

Member First Name

Member Last Name

Member Title/ Position

Member’s Voting Power
(Expressed as a percentage)

Membership Type

ACO Participant Legal Business Name, if applicable

Joshua

Hill

Chair

5%

ACO Participant Representative

Hill Medical Associates, LLP

Jared

Brinker

Vice Chair

5%

ACO Participant Representative

Grace Clinic of Lubbock

Benjamin

Batson

Member

5%

ACO Participant Representative

Covenant Medical Group

Jeremy

Brown

Member

5%

ACO Participant Representative

Covenant Medical Group

Allan

Camacho

Member

5%

ACO Participant Representative

Covenant Medical Group

Christopher

Collins

Member

5%

ACO Participant Representative

Grace Clinic of Lubbock

Steven

Crow

Member

5%

ACO Participant Representative

Covenant Medical Group

Ethan

Dalley

Member

5%

Community Stakeholder Representative

N/A

Jeremy

Dalton

Member

5%

ACO Participant Representative

Covenant Medical Group

Dominique

Foster

Member

5%

ACO Participant Representative

Covenant Medical Group

Swetha

Gadwala

Member

5%

Community Stakeholder Representative

N/A

Kompal

Parmar

Member

5%

ACO Participant Representative

Covenant Medical Group

Christopher

Rose

Member

5%

ACO Participant Representative

Christopher R. Rose, MD, PA

Caleb

Sallee

Member

5%

ACO Participant Representative

SWAT Surgical Associates, LLP

Lauren

Schaub

Member

5%

ACO Participant Representative

Covenant Medical Group

Karen

Soriano

Member

5%

ACO Participant Representative

Covenant Medical Group

Jason

Strefling

Member

5%

ACO Participant Representative

Covenant Medical Group

Kirk

Tiemann

Member

5%

ACO Participant Representative

Kirk J Tiemann, MD, PA

Andrew

West

Member

5%

ACO Participant Representative

Covenant Medical Group

Marissa

Yates

Member

5%

ACO Participant Representative

Covenant Medical Group

Member's voting power may have been rounded to reflect a total voting power of 100 percent.

Key ACO Clinical and Administrative Leadership:

ACO Executive: Walter Cathey

Medical Director: Christopher Collins, MD

Compliance Officer: Amy Riedel

Quality Assurance/Improvement Officer: Lisa Barrington, Ashlyn Frazier

Associated Committees and Committee Leadership

Committee Name

Committee Leader Name and Position

Quality and Credentialing

Christopher Collins, MD, Chair

Population Health and Finance

Steven Crow, MD, Chair

Types of ACO Participants, or Combinations of Participants, That Formed the ACO:

  • Networks of individual practices of ACO professionals

  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses:

  • Fourth Agreement Period

  • Performance Year 2026, N/A

  • Performance Year 2025, N/A

  • Third Agreement Period

  • Performance Year 2024, $5,243,334.43

  • Performance Year 2023, $5,249,166.98

  • Performance Year 2022, $5,349,938.00

  • Performance Year 2021, $3,392,164.15

  • Performance Year 2020, $2,467,946.55

  • Performance Year 2019, $0.00

  • Second Agreement Period

  • Performance Year 2019, $0.00

  • Performance Year 2018, $2,415,533.45

  • Performance Year 2017, $282,266.24

  • First Agreement Period

  • Performance Year 2016, $2,659,326.89

  • Performance Year 2015, N/A

  • Performance Year 2014, $2,542,944.50

Note: Our ACO participated in multiple performance years during Calendar Year 2019. The shared

savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or

losses across all performance years in 2019 and is shown under all agreement periods in which the ACO

operated during Calendar Year 2019.

Shared Savings Distribution:

  • Fourth Agreement Period

  • Performance Year 2026

  • Proportion invested in infrastructure: N/A

  • Proportion invested in redesigned care processes/resources: N/A

  • Proportion of distribution to ACO participants: N/A

  • Performance Year 2025

  • Proportion invested in infrastructure: N/A

  • Proportion invested in redesigned care processes/resources: N/A

  • Proportion of distribution to ACO participants: N/A

  • Third Agreement Period

  • Performance Year 2024

  • Proportion invested in infrastructure: 20%

  • Proportion invested in redesigned care processes/resources: 20%

  • Proportion of distribution to ACO participants: 60%

  • Performance Year 2023

  • Proportion invested in infrastructure: 20%

  • Proportion invested in redesigned care processes/resources: 20%

  • Proportion of distribution to ACO participants: 60%

  • Performance Year 2022

  • Proportion invested in infrastructure: 25%

  • Proportion invested in redesigned care processes/resources: 25%

  • Proportion of distribution to ACO participants: 50%

  • Performance Year 2021

  • Proportion invested in infrastructure: 25%

  • Proportion invested in redesigned care processes/resources: 25%

  • Proportion of distribution to ACO participants: 50%

  • Performance Year 2020

  • Proportion invested in infrastructure: 26%

  • Proportion invested in redesigned care processes/resources: 20%

  • Proportion of distribution to ACO participants: 54%

  • Performance Year 2019

  • Proportion invested in infrastructure: N/A

  • Proportion invested in redesigned care processes/resources: N/A

  • Proportion of distribution to ACO participants: N/A

  • Second Agreement Period

  • Performance Year 2019

  • Proportion invested in infrastructure: N/A

  • Proportion invested in redesigned care processes/resources: N/A

  • Proportion of distribution to ACO participants: N/A

  • Performance Year 2018

  • Proportion invested in infrastructure: 17%

  • Proportion invested in redesigned care processes/resources: 35%

  • Proportion of distribution to ACO participants: 48%

  • Performance Year 2017

  • Proportion invested in infrastructure: 25%

  • Proportion invested in redesigned care processes/resources: 8%

  • Proportion of distribution to ACO participants: 66%

  • First Agreement Period

  • Performance Year 2016

  • Proportion invested in infrastructure: 25%

  • Proportion invested in redesigned care processes/resources: 8%

  • Proportion of distribution to ACO participants: 66%

  • Performance Year 2015

  • Proportion invested in infrastructure: N/A

  • Proportion invested in redesigned care processes/resources: N/A

  • Proportion of distribution to ACO participants: N/A

  • Performance Year 2014

  • Proportion invested in infrastructure: 25%

  • Proportion invested in redesigned care processes/resources: 25%

  • Proportion of distribution to ACO participants: 50%

Note: Our ACO participated in multiple performance years during Calendar Year 2019. The distribution of

shared savings reported for Performance Year 2019 therefore represents the distribution of the net

shared savings across all performance years in 2019 and is shown under all agreement periods in which

the ACO operated during Calendar Year 2019.

Quality Performance Results

2024 Quality Performance Results:

Quality performance results are based on the CMS Web Interface collection type.

Measure #

Measure Title

Collection Type

Performance Rate

Current Year Mean Performance Rate (Shared Savings Programs ACOs)

321

CAHPS for MIPS

CAHPS for MIPS Survey

8.7

6.67

479*

Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups

Administrative Claims

0.1335

0.1517

484*

Clinician and Clinician Group Riskstandardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC)

Administrative Claims

-

37

318

Falls: Screening for Future Fall Risk

CMS Web Interface

91.53

88.99

110

Preventative Care and Screening: Influenza Immunization

CMS Web Interface

67.43

68.6

226

Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention

CMS Web Interface

70.83

79.98

113

Colorectal Cancer Screening

CMS Web Interface

81.63

77.81

112

Breast Cancer Screening

CMS Web Interface

81.17

80.93

438

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

CMS Web Interface

80.16

86.5

370

Depression Remission at Twelve Months

CMS Web Interface

27.16

17.35

001*

Diabetes: Hemoglobin A1c (HbA1c) Poor Control

CMS Web Interface

9.14

9.44

134

Preventative Care and Screening: Screening for Depression and Follow-up Plan

CMS Web Interface

80.86

81.46

236

Controlling High Blood Pressure

CMS Web Interface

74.5

79.49

CAHPS-1

Getting Timely Care, Appointments, and Information

CAHPS for MIPS Survey

88.5

83.7

CAHPS-2

How Well Providers Communicate

CAHPS for MIPS Survey

95.78

93.96

CAHPS-3

Patient’s Rating of Provider

CAHPS for MIPS Survey

95.74

92.43

CAHPS-4

Access to Specialists

CAHPS for MIPS Survey

80.39

75.76

CAHPS-5

Health Promotion and Education

CAHPS for MIPS Survey

60.46

65.48

CAHPS-6

Shared Decision Making

CAHPS for MIPS Survey

63.16

62.31

CAHPS-7

Health Status and Functional Status

CAHPS for MIPS Survey

75.43

74.14

CAHPS-8

Care Coordination

CAHPS for MIPS Survey

87.67

85.89

CAHPS-9

Courteous and Helpful Office Staff

CAHPS for MIPS Survey

93.87

92.89

CAHPS-11

Stewardship of Patient Resources

CAHPS for MIPS Survey

29.78

26.98

For previous years’ Financial and Quality Performance Results, please visit: Data.cms.gov

*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day,

All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and

Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple

Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure

performance.

*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple

Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying

Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and

ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs

may not be representative of the care provided by these ACOs' providers overall. Additionally, many of

these ACOs do not have a performance rate calculated due to not meeting the minimum of 18

beneficiaries attributed to non-QP providers.

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver:

  • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612

Join Covenant Health Partners

Click Here
Join Covenant Health Partners